Thus, the abnormally enhanced innate immune response observed in Mecp2-deficienct meningeal immunity may participate in the onset and progression of RTT by causing low-grade neuroinflammation, as reported by Pecorlli et al. This evidence concerns the gene MECP2 and Rett syndrome.